BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-22 Cr | ₹-1.05 Cr | ₹-11 Cr | ₹-28 Cr | ₹-5.97 Cr |
What is the latest Cash Flow from Investing Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-22 Cr |
| Mar2024 | ₹-1.05 Cr |
| Mar2023 | ₹-11 Cr |
| Mar2022 | ₹-28 Cr |
| Mar2021 | ₹-5.97 Cr |
How is Cash Flow from Investing Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-22 Cr | Negative | |
| Mar2024 | ₹-1.05 Cr | Negative | |
| Mar2023 | ₹-11 Cr | Negative | |
| Mar2022 | ₹-28 Cr | Negative | |
| Mar2021 | ₹-5.97 Cr | - | |
Compare Cash Flow from Investing Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹113.5 Cr | -7.2% | -14% | -68.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹278,657.0 Cr | -0% | 7.5% | -1.7% | Stock Analytics | |
| REDINGTON | ₹19,927.4 Cr | -2.4% | -0.1% | 14% | Stock Analytics | |
| HONASA CONSUMER | ₹9,954.7 Cr | 0.9% | 8.5% | 47% | Stock Analytics | |
| MMTC | ₹9,414.0 Cr | -3.1% | -2.7% | 3.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,417.4 Cr | 2.1% | 8.9% | 30% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -7.2% |
-14% |
-68.5% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses